Physician profile
Benjamin Jon Nelson
NPI 1023375011
$5,178.93
in general payments reported to CMS, 2019-2025
44 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $264 · 2021: $271 · 2022: $728 · 2023: $1,170 · 2024: $1,147 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,573.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $868.59 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $562.45 | 2019-2025 | Xtandi |
| Pfizer INC. | $449.78 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $285.21 | 2020-2025 | Prolaris |
| Abbvie INC. | $283.84 | 2020-2025 | |
| Procept Biorobotics Corporation | $281.04 | 2023-2025 | Aquabeam Robotic System |
| Janssen Biotech, INC. | $254.50 | 2020-2025 | Erleada |
| Antares Pharma, INC. | $209.13 | 2019-2025 | Xyosted |
| Urovant Sciences INC | $161.25 | 2022 | |
| Merck Sharp & Dohme LLC | $157.46 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Medtronic, INC. | $140.47 | 2021-2024 | Interstim |
| Urogen Pharma, INC. | $119.92 | 2022-2024 | Jelmyto |
| Telix Pharmaceuticals | $111.01 | 2023-2025 | Illuccix |
| Coloplast Corp | $109.75 | 2023-2025 | Speedicath |
| Boston Scientific Corporation | $107.08 | 2019-2023 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.